Prevalence of dementia and regional brain syndromes in long-standing Parkinson's disease

Parkinsonism and Related Disorders

Volumn 5, Issue 3, 1999, Pages 103-110

  Wallin, A ^a   Jennersjo C ^b   Granerus A K ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Alzheimer type dementia; Fronto subcortical type of dementia; Mental symptoms

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BROMOCRIPTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEVODOPA; SELEGILINE;

AGED; ARTICLE; BRAIN DISEASE; BRAIN REGION; CLINICAL FEATURE; CONTROLLED STUDY; DELIRIUM; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MOTOR DYSFUNCTION; ORGANIC PSYCHOSYNDROME; PARKINSON DISEASE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RATING SCALE;

EID: 0033198098     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(99)00018-8     Document Type: Article

References (39)

1. Gibb W.R.G. Dementia and Parkinson's disease. Br J Psychiatry. 154:1989;596-614.
2. Rajput A.H. Prevalence of dementia in Parkinson's disease. Huber S.J., Cummings J.L. Parkinson's disease. Neurobehavioural aspects. 1992;119-131 Oxford University Press, New York.
3. Tandberg E., Larsen J.P., Aarsland D., Jeffrey L., Cummings M.D. The occurrence of depression in Parkinson's disease. Arch Neurol. 53:1996;175-179.
4. Benson D.F. Parkinsonian dementia. Cortical or subcortical? Hassler R.G., Christ J.F. Advances in neurology: Parkinsonian-specific motor and mental disorder. 40:1984;235-240 Raven Press, New York.
5. Boller F. Mental status of patients with Parkinson's disease. J Clin Neuropsychol. 2:1980;157-172.
6. Cummings J.L. Intellectual impairment in Parkinson's disease: clinic, pathologic, biochemical correlates. J Geriatr Psychiatry Neurol. 1:1988;24-36.
7. Wallin A., Blennow K. Neurologic motor signs in early- and late-onset Alzheimer's disease. Dementia. 3:1992;314-319.
8. Wallin A., Blennow K., Gottfries C.G. Subcortical symptoms predominate in vascular dementia. Int J Geriatr Psychiatry. 6:1991;137-146.
9. Wallin A., Blennow K., Edman Å., Månsson J.E. Decreased lumbar CSF levels of monoamine metabolites in vascular dementia. Int Psychogeriatrics. 8:1996;425-436.
10. Perry R.H., Irving D., Blessed G., Fairbairn A., Perry E.K. Senile dementia of Lewy body type. A clinical and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci. 95:1990;119-139.
11. Brown R.G., Marsden C.D. How common is dementia in Parkinson's disease? Lancet. 2:(8414):1984;1262-1265.
12. Albert M.L., Feldman R.G., Willis A.L. The `subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 37:1974;121-130.
13. Boller F., Mizutani T., Roessman V., Gambetti P. Parkinson disease, dementia, and Alzheimer's disease: clinicopathological correlations. Ann Neurol. 7:1980;329-335.
14. Factor S.A., Molho E.S., Podskalny G.D., Brown D. Parkinson's disease: drug-induced psychiatric states. Weiner W.J., Lang A.E. Advances in neurology: Behavioural neurology of movement disorders. 65:1995;115-138 Raven Press, New York.
15. Friedman J.H. Psychotic symptoms in Parkinson's disease. J Am Geriatr Soc. 2:1997;252.
16. Mayeux R. Depression and dementia in Parkinson's disease. Marsden C.D., Fahn S. Movement disorders. 1982;75-79 Butterworths, Stoneham, MA.
17. Fall P.A., Axelson O., Fredriksson M., Hansson G., Lindvall B., Olsson J., Granerus A.K. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. J Clin Epidemiol. 49:(6):1996;637-641.
18. Doll R. Cancer incidence in five continents. Waterhouse J., Miur C., Correa P., Powell J. IARC Scientific Publication No. 15. III:1976;453-459 International Agency for Research on Cancer, Lyon.
19. Stacy M., Jancovic J. Differential diagnosis of Parkinson's disease and the Parkinson plus syndromes. Neurol Clin. 10:(2):1992;341-359.
20. Wallin A., Edman Å., Blennow K., Gottfries C.G., Karlsson I., Regland B., Sjögren M. Stepwise comparative status analysis (STEP) - a tool for the identification of various regional brain syndromes in dementia. J Geriatr Psychiatry Neurol. 9:1996;185-199.
21. Diagnostic and statistical manual of mental disorders. 3 :1987;American Psychiatric Association, Washington DC.
22. Diagnostic and statistical manual of mental disorders. 4 :1994;American Psychiatric Association, Washington DC.
23. Fahn S., Eltor R.L. Unified Parkinson's disease rating scale. Fahn S., Marsden C.D., Calne D.B., Goldstein M. Recent developments in Parkinson's disease. 2:1987;153-163 Macmillan Health Care Information, Florham Park, NJ. see also pp. 293-304.
24. Folstein M., Folstein S., McHugh P. "Mini-mental-state" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-198.
25. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology. 17:1967;427-442.
26. Webster D. Clinical analysis of the disability in Parkinson's disease. Mod Treatm. 5:(2):1968;257-282.
27. Rajput A.H., Offord K.P., Bearld C.M., Kurland L.T. A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology. 37:1987;226-232.
28. Breteler M.M., de Groot R.R., van Roumunde L.K., Hofman A. Risk of dementia in patients with Parkinson's disease, epilepsy, and severe head trauma: a register based follow up study. Am J Epidemiology. 142:(12):1995;1300-1305.
29. Jorm A.F., Korten A.E., Henderson A.S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychatr Scand. 76:1987;465-479.
30. Hofman A., Rocca W.A., Brayne C., Clarke M., Cooper B., Copeland J.R., Dartigues J.F., da Silva Droux A., Hagnell O., et al. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Int J Epidemiol. 20:(3):1991;736-748.
31. Martilla R.J., Rinne U.K. Dementia in Parkinson's disease. Acta Neurol Scand. 54:1976;431-441.
32. Aarsland D., Tandberg E., Larsen J.P., Cummings J.F. Frequency of dementia in Parkinson's disease. Arch Neurol. 53:1996;538-542.
33. Tison F., Dartigues J.F., Auriacombe S., Letenneur L., Boller F., Alperavitch A. Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals. Neurology. 45:1995;705-708.
34. Marder K., Tang M.X., Cote L., Stern Y., Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol. 52:1995;695-701.
35. Sjögren T., Sjögren H., Lindgren Å. Morbus Alzheimer and morbus Pick: a genetic, clinical and patho-anatomical study. Acta Psych Neurol Scand. 82 (suppl):1952;66-115.
36. Blennow K., Wallin A., Gottfries C.G. Presence of parieto-temporal symptomatology distinguishes early- and late-onset Alzheimer's disease. Int J Geriatr Psychiatry. 6:1991;147-154.
37. Wallin A., Blennow K., Scheltens Ph. Research criteria for clinical diagnosis of `pure' Alzheimer's disease. Drugs Today. 30:1994;265-273.
38. Mortimer J.A., Christensen K.J., Webster D.D. Parkinsonian dementia. Fredriks J.A.M. Handbook of clinical neurology: neurobehavioural disorders. 2 (46):1985;371-384 Elsevier Science, Amsterdam.
39. Mahler M.E., Cummings J.L. Alzheimer disease and dementia of Parkinson's disease: comparative investigations. Adad-ij. 4:1990;133-149.